🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cyclophosphamide is a chemotherapy agent with known activity in myeloma. Th...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2008-09
Trial ID
NCT00750815
Treatments Being Tested
This is a phase II, multicenter, open label, nonrandomized study to evaluat...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2009-09
Trial ID
NCT01160484
Treatments Being Tested
The purpose of this study is to determine whether doxorubicin HCL liposome ...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00561743
Treatments Being Tested
This phase I trial studies side effects of daratumumab, bortezomib, dexamet...
Status
Withdrawn
Location
City of Hope Medical Center
Start Date
2018-10-25
Trial ID
NCT03591744
Treatments Being Tested
Multiple myeloma (MM) is a common malignant hematology disease. The develop...
Status
Unknown
Location
Department of Hematology, Provincial Hospital Affiliated to Shandong University
Start Date
2019-03-30
Trial ID
NCT03908138
The goal of this clinical research study is to evaluate the safety and effe...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2014-09
Trial ID
NCT02206425
Treatments Being Tested
PRIMARY STUDY OBJECTIVES * To evaluate the efficacy of the combination of ...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2005-06
Trial ID
NCT00148317
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride li...
Status
Unknown
Location
Arizona Clinical Research Center, Incorporated
Start Date
2008-07
Trial ID
NCT00742404
RATIONALE: Drugs used in chemotherapy, such as pegylated liposomal doxorubi...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2008-11
Trial ID
NCT00849251
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00458705
Treatments Being Tested